Feb 1 (Reuters) - Mercator Medical SA MRCP.WA :
* PRELIM Q4 NET LOSS AT 49.2 MILLION ZLOTYS VERSUS PROFIT OF
4.9
MILLION ZLOTYS Y/Y
* PRELIM Q4 SALES REVENUE 110.8 MILLION ZLOTYS VERSUS 278.3
MILLION ZLOTYS YEAR AGO
* PRELIM Q4 EBITDA LOSS 35.9 MILLION ZLOTYS VERSUS PROFIT OF
4.7
MILLION ZLOTYS Y/Y
* IS CURRENTLY CONDUCTING IMPAIRMENT TESTS ON GROUP'S ASSETS
* ANY ADJUSTMENT OF VALUE OF ASSETS TO BE INCLUDED IN FY
REPORT
* IMPAIRMENT TESTS ARE RELATED TO CHANGES IN GLOBAL BUSINESS
ENVIRONMENT, I.E. GLOVE PRICING TRENDS AND SUPPLY-DEMAND
SITUATION
Source text for Eikon: ID:nEM1MKskPa
Further company coverage: MRCP.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))